Alvelestat (MPH966) Trial for Bronchiolitis Obliterans Syndrome Post-HSCT Initiated
A clinical trial is underway to evaluate the safety and efficacy of alvelestat (MPH966) in patients with bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.